Erica Moretti
Prato, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencing.
Journal: Genome medicine
Published: August 01, 2025
Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer.
Journal: NPJ breast cancer
Published: September 19, 2024
Prospective study on Oncotype DX® assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: The POST trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 06, 2024
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial.
Journal: JCO precision oncology
Published: March 01, 2024
MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples.
Journal: Briefings in bioinformatics
Published: November 16, 2022
Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer.
Journal: International journal of molecular sciences
Published: April 08, 2021
Cell-Free DNA-Methylation-Based Methods and Applications in Oncology.
Journal: Biomolecules
Published: October 27, 2020
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial.
Journal: Breast cancer research : BCR
Published: October 16, 2020
A Dose-finding Study of Metronomic Oral Vinorelbine in Combination With Oral Cyclophosphamide and Bevacizumab in Patients With Advanced Breast Cancer.
Journal: Clinical breast cancer
Published: June 07, 2020
Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 08, 2019
Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial.
Journal: Breast cancer research : BCR
Published: May 31, 2019
Last Updated: 09/26/2026